Jonathan M. Marron, MD, MPH
Attending Physician, Pediatric Hematology/Oncology; Clinical Ethicist, Boston Children's Hospital
Instructor of Pediatrics, Harvard Medical School
Image
Jonathan M. Marron, MD, MPH
Attending Physician, Pediatric Hematology/Oncology; Clinical Ethicist, Boston Children's Hospital
Instructor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
David Geffen School of Medicine at UCLA
2008
Los Angeles
CA
Internship
Pediatrics
Lucile Packard Children’s Hospital at Stanford University
2009
Palo Alto
CA
Residency
Pediatrics
Lucile Packard Children’s Hospital at Stanford University
2011
Palo Alto
CA
Fellowship
Clinical Ethics
MacLean Center for Clinical Medical Ethics, University of Chicago
2012
Chicago
IL
Fellowship
Pediatric Hematology/Oncology
Boston Children’s Hospital/Dana-Farber Cancer Institute
2015
Boston
MA
Fellowship
Health Services Research
Harvard Medical School
2016
Boston
MA
Graduate School
MPH
Harvard T.H. Chan School of Public Health
2016
Boston
MA
Certifications
American Board of Pediatrics (General)
Professional History
Dr. Marron received his medical degree from the David Geffen School of Medicine at UCLA in 2008. He completed his residency in Pediatrics at Stanford University and his fellowship in Clinical Medical Ethics at the University of Chicago followed by his fellowship in Pediatric Hematology/Oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute. Dr. Marron also received an MPH in 2016 from the Harvard T.H. Chan School of Public Health. Jonathan cares for pediatric oncology patients in the inpatient setting at Boston Children’s Hospital and in the outpatient clinic at the Dana-Farber Cancer Institute. His research interests are in ethics and decision-making, health services, clinical genomics, informed consent, and medical uncertainty. Much of Dr. Marron’s current work focuses on patient, parent, and physician decision-making regarding pediatric precision cancer medicine. He also teaches medical ethics to medical students and graduate students through his role as teaching faculty at the Harvard Medical School Center for Bioethics.
Publications
Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley. View Abstract
Potentially Inappropriate Treatment: Competing Ethical Considerations. View Abstract
Participatory Practice in Pursuit of Social Justice. View Abstract
Boots on the Ground in Childhood Cancer Drug Shortages: a multilevel approach. View Abstract
Parents' Experiences With and Preferences for Receiving Information About Tumor Genomic Sequencing: Findings From a Qualitative Study and Implications for Practice. View Abstract
Clinical ethics consultation services: public-facing information on NCI-designated cancer center websites. View Abstract
The Closing of an Academic Children's Hospital: Ethical Considerations for Graduate Medical Education. View Abstract
Everyday Clinical Ethics: Essential Skills and Educational Case Scenarios. View Abstract
Perspectives of pediatric oncologists on referral for CAR-T therapy: a mixed methods pilot study. View Abstract
Establishing and Defining an Approach to Climate Conscious Clinical Medical Ethics. View Abstract
A Communication and Decision-Making Framework for Pediatric Precision Medicine. View Abstract
Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care. View Abstract
Shifting from Equality toward Equity: Addressing Disparities in Research Participation for Clinical Cancer Research. View Abstract
Prognosis-Based Definitions for Potentially Inappropriate Treatment: Still Flawed, If Not Futile. View Abstract
ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages. View Abstract
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives. View Abstract
Parents' and adolescents' perspectives and understanding of information about childhood cancer precision medicine. View Abstract
Potentially Inappropriate Treatment: Competing Ethical Considerations. View Abstract
Can the Extraordinary Become Ordinary? Re-Examining the Ethics of ECMO-DT. View Abstract
Clinical ethics consultation documentation in the era of open notes. View Abstract
Fear of Saying No (FOSNO): Setting Boundaries With Our Patients and Ourselves. View Abstract
Pediatric Brain Death Testing Over Parental Objections: Not an Ethically Preferable Option. View Abstract
The role of ethicists in pediatric hematology/oncology: Current status and future needs. View Abstract
Words Matter. View Abstract
Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review. View Abstract
What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes. View Abstract
Ethics Consultation in Oncology: The Search for Quality in Quantity. View Abstract
A Process Framework for Ethically Deploying Artificial Intelligence in Oncology. View Abstract
Ethics-Centered Guidelines for Social Media Use by Oncology Professionals: A Call to Action. View Abstract
Could Behavioral Economics Mitigate Shortcomings in Shared Decision-Making? View Abstract
Picture a Professional: Rethinking Expectations of Medical Professionalism Through the Lens of Diversity, Equity, and Inclusion. View Abstract
The Case of Billy Best: 25 Years Later. View Abstract
Striving for equity: Patient prioritization during a critical cancer drug shortage. View Abstract
Adolescent Shared Decision-Making: Where We Have Been and Where We are Going. View Abstract
The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path Forward. View Abstract
Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy. View Abstract
The Complicated Legacy of Cassandra Callender: Ethics, Decision-making, and the Role of Adolescents. View Abstract
Structural Racism in the COVID-19 Pandemic: Don't Forget about the Children! View Abstract
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. View Abstract
Ethical Challenges in Pediatric Oncology Care and Clinical Trials. View Abstract
Communicating uncertainty: A step in the right direction? View Abstract
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. View Abstract
Informed consent for genetic testing in hematology. View Abstract
Waging War on War Metaphors in Cancer and COVID-19. View Abstract
How should we approach parental refusals of opioids on behalf of children in the perioperative setting? A practical approach based on ethical theory. View Abstract
Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic. View Abstract
A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology. View Abstract
Medical Decision-Making in Oncology for Patients Lacking Capacity. View Abstract
Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement. View Abstract
Stopping Leukemia in Its Tracks: Should Preemptive Hematopoietic Stem-Cell Transplantation be Offered to Patients at Increased Genetic Risk for Acute Myeloid Leukemia? View Abstract
Ethical Issues Considered When Establishing a Pediatrics Gender Surgery Center. View Abstract
Prognostication and Communication in Oncology. View Abstract
Identification Before Prescription: Necessary Changes for the Support of Transgender Youth. View Abstract
Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors. View Abstract
Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine. View Abstract
Justice in CRISPR/Cas9 Research and Clinical Applications. View Abstract
Not All Disagreements Are Treatment Refusals: The Need for New Paradigms for Considering Parental Treatment Requests. View Abstract
Counterpoint: Provider moral distress in end-of-life oncology care is a moral crutch. View Abstract
Intended and unintended consequences: Ethics, communication, and prognostic disclosure in pediatric oncology. View Abstract
Is There Ever a Role for the Unilateral Do Not Attempt Resuscitation Order in Pediatric Care? View Abstract
Ethical considerations in genomic testing for hematologic disorders. View Abstract
Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. View Abstract
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience. View Abstract
Against "Healthy Paternalism" at the End of Life. View Abstract
Multimodality Treatment of Pediatric Esthesioneuroblastoma. View Abstract
When to say when: How aggressively to care for children with multiply relapsed cancer? View Abstract
Physician attitudes toward industry: room for improvement. View Abstract
Ethical issues in innovative colorectal surgery. View Abstract